SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Director Declaration

1 Sep 2017 14:47

RNS Number : 6279P
Consort Medical PLC
01 September 2017
 

 

 

Consort Medical plc

Director Declaration

 

In accordance with Rule 9.6.14 of the UK Listing Rules, Consort Medical plc ('the Company') gives notice that Ms Charlotta Ginman, a non-executive Director of the Company, has been appointed a non-executive Director of Keywords Studios plc with effect from 1 September 2017.

 

Enquiries:

Consort Medical plc Tel: +44 1442 867920

John Ilett - Company Secretary

 

 

Consort Medical plc is a leading, global, single source drug and delivery device company (CDMO). We are at the leading edge of innovation and we are committed to investing in patient, clinician and customer driven innovation to create new treatments, new markets and new opportunities.

Our businesses 

Bespak is a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including respiratory, nasal, and injectable products, and the manufacture of devices for the point of care diagnostics market. www.bespak.com. 

Aesica is a leading provider of finished dose and active pharmaceutical ingredient (API) development and manufacturing services to pharmaceutical partners. www.aesica-pharma.com. 

We employ more than 2,000 people globally of which 1,400 are located in the UK. We have UK facilities in King's Lynn, Cambridge, Nelson, Milton Keynes, Cramlington, Queenborough and Hemel Hempstead, German facilities in Monheim and Zwickau and a facility in Pianezza, Italy. Consort Medical is a public company quoted on the premium list of the London Stock Exchange (LSE: CSRT). www.consortmedical.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNEADNFELKXEFF
Date   Source Headline
20th Nov 20192:42 pmRNSForm 8.3 - Consort Medical PLC
20th Nov 20192:15 pmEQSForm 8.3 - The Vanguard Group, Inc.: Consort Medical plc
20th Nov 20192:12 pmRNSForm 8.3 - Consort Medical Plc
20th Nov 201910:17 amBUSForm 8.3 - Consort Medical plc - Replacement
20th Nov 20198:45 amGNWForm 8.5 (EPT/RI) - Consort Medical plc
19th Nov 20194:24 pmRNSForm 8.3 - Consort Medical plc
19th Nov 20193:31 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: Consort Medical PLC
19th Nov 20193:20 pmRNSForm 8.3 - Consort Medical plc
19th Nov 20193:12 pmRNSForm 8.3 - Consort Medical Plc
19th Nov 20193:00 pmBUSForm 8.3 - Consort Medical Plc
19th Nov 20192:56 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: Hayne Publishing Group PLC
19th Nov 20192:53 pmRNSForm 8.3 - Consort Medical Plc
19th Nov 20192:24 pmRNSForm 8.3 - Consort Medical Plc
19th Nov 20192:21 pmRNSForm 8.3 - Consort Medical plc
19th Nov 20192:17 pmRNSForm 8.3 - Consort Medical PLC
19th Nov 20192:16 pmRNSForm 8.3 - Consort Medical plc
19th Nov 20192:04 pmEQSForm 8.3 - The Vanguard Group, Inc.: Consort Medical plc
19th Nov 20191:27 pmGNWInvesco Ltd.: Form 8.3 - OPD Consort Medical PLC
19th Nov 201912:45 pmRNSForm 8.3 - [Consort Medical plc]
19th Nov 201911:46 amRNSForm 8.3 - Consort Medical Plc
19th Nov 201911:36 amRNSForm 8.3 - Consort Medical plc
19th Nov 201911:36 amRNSForm 8.3 - Consort Medical plc
19th Nov 201911:33 amRNSForm 8.3 - Consort Medical Plc
19th Nov 201911:23 amGNWForm 8.5 (EPT/RI) - Consort Medical Plc
19th Nov 201910:02 amRNSForm 8.3 - Consort Medical Plc
19th Nov 20199:20 amRNSForm 8.3 - CONSORT MEDICAL PLC
18th Nov 20193:43 pmEQSForm 8.3 - Consort Medical Plc
18th Nov 20193:15 pmBUSForm 8.3 - Consort Medical plc
18th Nov 20193:00 pmBUSForm 8.3 - Consort Medical plc
18th Nov 20192:31 pmBUSForm 8.3 - Consort Medical Plc
18th Nov 20192:08 pmRNSForm 8.3 - Consort Medical Plc
18th Nov 20197:00 amRNSRecommended Cash Offer
13th Nov 20199:14 amRNSHolding(s) in Company
11th Nov 201911:23 amRNSDirector/PDMR Shareholding
4th Nov 20197:00 amRNSHolding(s) in Company
1st Nov 20197:00 amRNSDirector/PDMR Shareholding
18th Oct 20197:00 amRNSConsort Signs Development Agreement with Regeneron
14th Oct 20199:23 amRNSBlock listing Interim Review
9th Oct 201910:14 amRNSDirector/PDMR Shareholding
13th Sep 20199:03 amRNSDirector/PDMR Shareholding
11th Sep 20192:54 pmRNSResult of AGM
11th Sep 20197:00 amRNSAnnual General Meeting Trading Update
29th Aug 201912:06 pmRNSDirector/PDMR Shareholding
16th Aug 201911:08 amRNSDirector/PDMR Shareholding
12th Aug 20194:30 pmRNSDirector/PDMR Shareholding
12th Aug 20199:54 amRNSDirector/PDMR Shareholding
6th Aug 20197:00 amRNSDirector/PDMR Shareholding
31st Jul 20192:00 pmRNSAnnual Financial Report and AGM Notice
30th Jul 20197:00 amRNSDirector/PDMR Shareholding
25th Jul 20198:44 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.